MedTech Dive August 19, 2024
Edwards, which has made a series of acquisitions in recent months, is also investing $25 million in Singapore-based Genesis Medtech.
Dive Brief:
- Edwards Lifesciences has purchased a transcatheter aortic valve replacement (TAVR) system from Genesis Medtech that is designed to treat severe aortic regurgitation.
- The sale of Genesis’ JC Medical business includes intellectual property and commercial rights for the J-Valve system. Edwards will pay an upfront sum and potential sales-based milestone payments. A sale price was not disclosed in Genesis’ Monday announcement.
- Edwards has also made an equity investment of $25 million in Singapore-based Genesis to support product and market development efforts.
Dive Insight:
Edwards has been on an acquisition spree. In July, the heart valve specialist said...
Today's Sponsors
Today's Sponsor